Are Sleeping Disorders Associated With Visceral Hypersensitivity in Irritable Bowel Syndrome Patients ?
Key facts
- Who runs it
- University Hospital, Rouen
- Where
- France1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 70 people enrolled
- Started
- 22 Sept 2020
- Ended
- 12 Nov 2025
- Type of study
- Interventional, 4 groups
- Treatments tested
- Barostat procedure
- Anxiety and Depression Evaluation
- Assessment of sleep quality
- Record updated
- 6 February 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- Healthy volunteers; Person aged over 18 years with no IBS and no Insomnia
- Patients with insomnia; Patient aged over 18 years with no IBS and no Insomnia
- Patients with IBS; Patient aged over 18 years with IBS
- patients with insomnia and IBS - Patient aged over 18 years with IBS
Who cannot take part
- Active chronic organic disease
- Hypersensitivity to Normacol
- Patient with blood dyscrasia disorder known or identified, anticoagulant or antiplatelet treatments
- Severe renal failure
- Anal pathology (anal fissure, hemorrhoidal thrombosis)
- Sodium retention
- Endometriosis
- Opioids consumption
- Change in chronic treatment in the last 30 days
- Rectal pathology
- Intestinal occlusion
- Person with administrative or judicial decision or under legal protection measure
- Patient participating in another trial in the last 30 days
- Pregnant or breastfeeding women
- Impossibility to keep fasting for 12 hours
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Visceral hypersensitivity is frequent in IBS population up to 60% and is correlated with severity and altered quality of life. Sleeping troubles are most frequent in IBS population. Insomnia is a frequent disorder with an important cost for healthcare. Insomnia could decrease pain threshold.
Read full original descriptionShow less
Visceral hypersensitivity was never measure in patients with insomnia. The hypothesis is IBS patients with insomnia probably have lower visceral pain threshold.
The objective is to assess pain threshold during a barostat procedure in in IBS patients with or without insomnia in comparison with healthy volunteers or patients with insomnia.
If the hypothesis are confirmed, insomnia should be look at in IBS patients and its treatments could improve visceral hypersensitivity and IBS symptoms.
The 4 groups in the trial
- Healthy volunteersOther group
Treatment: Barostat procedure, Anxiety and Depression Evaluation, and Assessment of sleep quality
- Patients with insomniaOther group
Treatment: Barostat procedure, Anxiety and Depression Evaluation, and Assessment of sleep quality
- Patients with irritable bowel syndromeOther group
Treatment: Barostat procedure, Anxiety and Depression Evaluation, and Assessment of sleep quality
- Patients with irritable bowel syndrome and insomniaTreatment being tested
Treatment: Barostat procedure, Anxiety and Depression Evaluation, and Assessment of sleep quality
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 6 February 2026